Drug Safety Labeling Changes - June 2015

Creator: Madhumathi Palaniappan
Keywords: FDA label changes June - 2015, Drug Name, Sections Modified, Contraindications, Precautions, Adverse Reactions

Written & Compiled by - Madhumathi Palaniappan

Medically Reviewed by - The Medindia Medical Review Team

Food and Drug Administration (FDA) announces important safety label changes for prescription drugs almost every month. By implementing the label changes the FDA warns a physician of new side- effects, adverse reactions, contra-indications and precautions necessary for a drug. This information is important for safe practice of medicine.

Key to Label Sections

C - Contraindications
W - Warnings
P - Precautions
AR - Adverse Reactions

Drug Name	Sections Modified
Drug Name	C	W	P	AR
Rufinamide - Oral Tablets and Oral Suspension	-
Cabazitaxel - Injection				-
Captopril - Tablets			-	-
Ceftriaxone - for Injection			-
Doxazosin -Extended Release Tablets	-
Doxycycline - Delayed Release Tablets	-			-
Drospirenone and Estradiol - Tablets	-			-
Drospirenone/ Ethinylestradiol/ Levomefolate - Tablets	-			-
Enjuvia (synthetic conjugated estrogens, B) Tablets
Pembrolizumab - Injection	-
Topotecan - Injection	-	-	-	-